The question of maintenance therapy is heavily debated between #myeloma specialists. Patients need to do their best to educate themselves on the facts and then make the best decision for themselves. Join us on Sep 21 @ 6PM Eastern to find out how. #mmsm myelomacrowd.org/event/the-ques…

VTE prophylaxis in NDMM, are we doing enough?

An amazing morning of hosting Dr Dan Sherbenou at the Huntsman. I applaud the push towards personalized treatment for all of our myeloma patients! Incredible ongoing work. PS. When in Salt Lake establishing collaborations, don’t forget to ski!

Great to see DREAMM2 published in The Lancet Oncology today!

There is something special about waiting for little cottonwood canyon to open after early AM avalanche work.

Get a whiff of the GRIFF!! Plasma Cell Pete
Presenting updated Griffin data. D-RVD> RVD in transplant eligible pts with respect to sCR and MRD. Endpoint that speak to my #myelennial heart. Some more infections in Dara arm but looks manageable and not high grade #mmsm #ASH19

Dr. Luciano Costa, thank you for your work and being real. Great talk. Best moment of ASH19. Luciano J Costa

Please don’t use Clarithromycin-Rd in anyone as a myeloma regimen. It’s basically like giving a lot more Dex. It is not effective and can be harmful. We have better regimens. #ASH19 Shaji Kumar

Great lunch today with great people!

Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time. No, just no. Prime time means you have clinical data, which is still on the way. ncbi.nlm.nih.gov/pubmed/31730582

With pride, great work Dr Stephens!

Best moment of the day - Nina Shah anointing Pete Voorhes as the AURIGA cheerleader! Gooooooooo Pete!

KARMMA3 and CAR-T cells have officially opened at the HCI!

Great talk by awechalekar on pitfalls of diagnosis of amyloidosis #amysm

Rational combinations of Oncolytics viruses with other treatments are rare. Checkpoint inhibition has preclinical justification with reovirus, and now here's a report of pyruvate dehydrogenase kinase inhibition. cancerres.aacrjournals.org/content/early/…

2019 Utah Amyloidosis Program, Dr Giovanni Palladini joins us to discuss amyloidosis! Great event and wonderful turnout!

Apple is kind enough to show us weekly screen time, I wonder if EPIC is going to do the same. It would be incredibly interesting (saddening) to see my average hours per day...